DJIA 16,979.13 59.54 0.35%
NASDAQ 4,526.48 -1.03 -0.02%
S&P 500 1,986.51 4.91 0.25%
market minute promo

4.21 0.03 (0.72%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

OXBT $4.21 0.72%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $4.25
Previous Close $4.18
Daily Range $4.10 - $4.26
52-Week Range $1.19 - $11.40
Market Cap $118.3M
P/E Ratio -1.54
Dividend (Yield) $0.00 (0.0%)
Volume 35,682
Average Daily Volume 122,591
Current FY EPS -$0.50

Sector

Services

Industry

Diversified Services

Oxygen Biotherapeutics, Inc. (OXBT) Description

Oxygen Biotherapeutics Inc. is engaged in the business of developing biotechnology products with a focus on oxygen delivery to tissue. Website: http://www.oxybiomed.com/

News & Commentary Rss Feed

Oxygen Biotherapeutics Expands TBI Trials to India, Seeks Partner

The drug development company is now looking for a pharmaceutical partner who could help take its experimental treatment through clinical trials.

Oxygen Biotherapeutics Highlights Recent Publicans Showing Potential Benefits of Levosimendan

Oxygen Bio: Insiders Register To Exit As Paid Promoters Hype Stock

Oxygen Biotherapeutics (OXBT) is Oversold: Can It Recover? - Tale of the Tape

Oxygen Biotherapeutics Announces Formation of Steering Committee for Phase 3 LEVO-CTS Trial of Levos

Oxygen Biotherapeutics Announces Formation of Steering Committee for Phase 3 LEVO-CTS Trial of Levosimendan

Oxygen Biotherapeutics Up on FDA News - Analyst Blog

Oxygen Biotherapeutics Inc. Provides an Update on Communication with the FDA Regarding Oxycyte Devel

Oxygen Biotherapeutics Inc. Provides an Update on Communication with the FDA Regarding Oxycyte Development Program; Hold Has Been Lifted

Healthcare Stocks Rising; Oxygen Biotherapeutics Sliding After Pricing $52 Mln Stock Offering

Sector Update: Healthcare

Morning Market Losers

After-Hours Movers for Mar. 17, 2014: FF, GALE Higher, OXBT, EOX, TWER, CHH Lower

See More OXBT News...

OXBT's Top Competitors

OXBT $4.21 (0.72%)
Current stock: OXBT
AMGN $132.68 (-0.26%)
Current stock: AMGN
GILD $100.79 (-0.48%)
Current stock: GILD
BIIB $342.58 (-0.94%)
Current stock: BIIB